PortfoliosLab logoPortfoliosLab logo
CDE vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CDE vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Coeur Mining, Inc. (CDE) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CDE achieves a -3.43% return, which is significantly lower than TGTX's 66.12% return. Over the past 10 years, CDE has underperformed TGTX with an annualized return of 7.09%, while TGTX has yielded a comparatively higher 21.61% annualized return.


CDE

1D
4.88%
1M
-12.77%
YTD
-3.43%
6M
-0.18%
1Y
86.96%
3Y*
74.15%
5Y*
9.92%
10Y*
7.09%

TGTX

1D
3.06%
1M
16.11%
YTD
66.12%
6M
57.96%
1Y
32.51%
3Y*
21.69%
5Y*
5.57%
10Y*
21.61%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CDE vs. TGTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CDE
Coeur Mining, Inc.
-3.43%211.71%75.46%-2.98%-33.33%-51.30%28.09%80.76%-40.40%-17.49%
TGTX
TG Therapeutics, Inc.
66.12%-0.96%76.23%44.38%-37.74%-63.48%368.65%170.73%-50.00%76.34%

Correlation

The correlation between CDE and TGTX is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.17

Correlation (All Time)
Calculated using the full available price history since May 3, 2010

0.14

Fundamentals

EPS

CDE:

$1.64

TGTX:

$2.87

PE Ratio

CDE:

10.46

TGTX:

17.23

PEG Ratio

CDE:

0.09

TGTX:

0.03

PS Ratio

CDE:

3.26

TGTX:

11.37

Total Revenue (TTM)

CDE:

$2.57B

TGTX:

$700.35M

Gross Profit (TTM)

CDE:

$909.07M

TGTX:

$581.54M

EBITDA (TTM)

CDE:

$1.23B

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CDE vs. TGTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CDE
CDE Risk / Return Rank: 7575
Overall Rank
CDE Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
CDE Sortino Ratio Rank: 7474
Sortino Ratio Rank
CDE Omega Ratio Rank: 7474
Omega Ratio Rank
CDE Calmar Ratio Rank: 7777
Calmar Ratio Rank
CDE Martin Ratio Rank: 7373
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 6363
Overall Rank
TGTX Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 6464
Sortino Ratio Rank
TGTX Omega Ratio Rank: 6363
Omega Ratio Rank
TGTX Calmar Ratio Rank: 6464
Calmar Ratio Rank
TGTX Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CDE vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Coeur Mining, Inc. (CDE) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CDETGTXDifference
Sharpe ratioReturn per unit of total volatility

+0.54

Sortino ratioReturn per unit of downside risk

+0.53

Omega ratioGain probability vs. loss probability

1.24

1.16

+0.07

Calmar ratioReturn relative to maximum drawdown

2.02

1.00

+1.02

Martin ratioReturn relative to average drawdown

4.02

1.81

+2.21

CDE vs. TGTX - Sharpe Ratio Comparison

The current CDE Sharpe Ratio is 1.23, which is higher than the TGTX Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of CDE and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CDE vs. TGTX - Drawdown Comparison

The maximum CDE drawdown since its inception was -99.40%, roughly equal to the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for CDE and TGTX.


Loading charts...

Drawdown Indicators


CDETGTXDifference

Max Drawdown

Largest peak-to-trough decline

-99.40%

-99.52%

+0.12%

Max Drawdown (1Y)

Largest decline over 1 year

-43.18%

-32.66%

-10.52%

Max Drawdown (3Y)

Largest decline over 3 years

-43.18%

-75.42%

+32.24%

Max Drawdown (5Y)

Largest decline over 5 years

-81.25%

-90.75%

+9.50%

Max Drawdown (10Y)

Largest decline over 10 years

-87.42%

-93.19%

+5.77%

Current Drawdown

Current decline from peak

-94.03%

-78.79%

-15.24%

Average Drawdown

Average peak-to-trough decline

-81.49%

-91.43%

+9.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.71%

18.04%

+3.67%

Volatility

CDE vs. TGTX - Volatility Comparison

Coeur Mining, Inc. (CDE) has a higher volatility of 22.43% compared to TG Therapeutics, Inc. (TGTX) at 15.65%. This indicates that CDE's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CDETGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.43%

15.65%

+6.78%

Volatility (6M)

Calculated over the trailing 6-month period

55.24%

34.28%

+20.96%

Volatility (1Y)

Calculated over the trailing 1-year period

70.98%

47.22%

+23.76%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

68.37%

87.77%

-19.40%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

68.85%

86.88%

-18.03%

Dividends

CDE vs. TGTX - Dividend Comparison

CDE's dividend yield for the trailing twelve months is around 0.12%, while TGTX has not paid dividends to shareholders.


PositionTTM
CDE
Coeur Mining, Inc.
0.12%
TGTX
TG Therapeutics, Inc.
0.00%

Financials

CDE vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between Coeur Mining, Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
856.19M
204.92M
(CDE) Total Revenue
(TGTX) Total Revenue
Values in USD except per share items

CDE vs. TGTX - Profitability Comparison

The chart below illustrates the profitability comparison between Coeur Mining, Inc. and TG Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%202220232024202520260
83.7%
Portfolio components
CDE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Coeur Mining, Inc. reported a gross profit of 0.00 and revenue of 856.19M. Therefore, the gross margin over that period was 0.0%.

TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

CDE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Coeur Mining, Inc. reported an operating income of 349.17M and revenue of 856.19M, resulting in an operating margin of 40.8%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

CDE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Coeur Mining, Inc. reported a net income of 246.76M and revenue of 856.19M, resulting in a net margin of 28.8%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.


Frequently Asked Questions


CDE and TGTX have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CDE has higher volatility (22.43%) compared to TGTX (15.65%). In terms of maximum drawdown, CDE dropped -99.40% vs TGTX's -99.52%.

CDE currently has the higher Sharpe Ratio (1.23 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CDE and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer